Drugs

Enzalutamide Data to Be Presented at ASCO GU Symposium

SAN FRANCISCO, CA and TOKYO: ...

Prana Announces That New York Academy of Sciences eBriefing Is Available Online

MELBOURNE, AUSTRALIA: 'Targeting Metals in Alzheimer's and Other Neurodegenerative Diseases' Symposium ...

Mergers and Acquisitions Remain Key in Big Pharma's 2013 Playbook, an Industrial Info News Alert

SUGAR LAND, TX: ...

Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes

SOUTH SAN FRANCISCO, CA: ...

Meditab Software Celebrates 15 Year Anniversary With Surescripts' 2012 White Coat of Quality Award

OAKLAND, CA: ...

Theravance Announces Exercise by Underwriters of Option to Purchase Additional $37.5 Million Convertible Subordinated Notes

SOUTH SAN FRANCISCO, CA: Company Has Also Entered Into Additional Capped Call Transactions in Connection With the Additional Notes ...

Sirona Biochem Announces Trading on OTCQX

VANCOUVER, BRITISH COLUMBIA: ...

NuPathe's Zecuity Approved by the FDA for the Acute Treatment of Migraine

CONSHOHOCKEN, PA: First FDA-Approved Migraine Patch Conference Call Scheduled January 18 at 8:30 a.m. EST ...

Theravance, Inc. to Offer $250 Million Convertible Subordinated Notes Due 2023

SOUTH SAN FRANCISCO, CA: Company Intends to Use a Portion of the Net Proceeds of the Offering to Pay for the Cost of Entering Into Capped Call Transactions ...

Xylitol Canada Announces Closing of $2 Million Private Placement

TORONTO, ONTARIO: ...